Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

445 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer.
Harris RE. Harris RE. Subcell Biochem. 2007;42:93-126. doi: 10.1007/1-4020-5688-5_4. Subcell Biochem. 2007. PMID: 17612047 Review.
Cancer chemoprevention by cyclooxygenase 2 (COX-2) blockade: results of case control studies.
Harris RE, Beebe-Donk J, Alshafie GA. Harris RE, et al. Subcell Biochem. 2007;42:193-212. doi: 10.1007/1-4020-5688-5_9. Subcell Biochem. 2007. PMID: 17612052 Review.
Antiangiogenesis: New Frontiers in Therapeutic Development--IBC's Fourth Annual International Symposium.
Harris RE. Harris RE. IDrugs. 2006 Dec;9(12):834-6. IDrugs. 2006. PMID: 17139568 No abstract available.
Reduced risk of human lung cancer by selective cyclooxygenase 2 (COX-2) blockade: results of a case control study.
Harris RE, Beebe-Donk J, Alshafie GA. Harris RE, et al. Int J Biol Sci. 2007 Jun 13;3(5):328-34. doi: 10.7150/ijbs.3.328. Int J Biol Sci. 2007. PMID: 17589567 Free PMC article.
Cyclooxygenase and lipoxygenase gene expression in the inflammogenesis of breast cancer.
Kennedy BM, Harris RE. Kennedy BM, et al. Among authors: harris re. Inflammopharmacology. 2018 May 7. doi: 10.1007/s10787-018-0489-6. Online ahead of print. Inflammopharmacology. 2018. PMID: 29736687
Ibuprofen and fatal lung cancer: A brief report of the prospective results from the Third National Health and Nutrition Examination Survey (NHANES III).
Bittoni MA, Carbone DP, Harris RE. Bittoni MA, et al. Among authors: harris re. Mol Clin Oncol. 2017 Jun;6(6):917-920. doi: 10.3892/mco.2017.1239. Epub 2017 May 5. Mol Clin Oncol. 2017. PMID: 28588790 Free PMC article.
Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors.
Harris RE, Beebe J, Alshafie GA. Harris RE, et al. J Exp Pharmacol. 2012 Aug 10;4:91-6. doi: 10.2147/JEP.S23826. eCollection 2012. J Exp Pharmacol. 2012. PMID: 27186121 Free PMC article. Review.
Cyclooxygenase-2 and the inflammogenesis of breast cancer.
Harris RE, Casto BC, Harris ZM. Harris RE, et al. Among authors: harris zm. World J Clin Oncol. 2014 Oct 10;5(4):677-92. doi: 10.5306/wjco.v5.i4.677. World J Clin Oncol. 2014. PMID: 25302170 Free PMC article. Review.
Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors.
Harris RE, Beebe-Donk J, Alshafie GA. Harris RE, et al. BMC Cancer. 2008 Aug 14;8:237. doi: 10.1186/1471-2407-8-237. BMC Cancer. 2008. PMID: 18702823 Free PMC article.
Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors.
Harris RE, Beebe-Donk J, Alshafie GA. Harris RE, et al. BMC Cancer. 2006 Jan 30;6:27. doi: 10.1186/1471-2407-6-27. BMC Cancer. 2006. PMID: 16445867 Free PMC article.
445 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback